CMC Biologics is engaged in clinical and commercial manufacturing of monoclonal antibodies, coagulation factors and therapeutic proteins.
Business Model:
Revenue: $5M
Employees: 201-500
CMC Biologics was acquired by
AGC.
The acquisition happend on 2016-12-20.
Details of the transaction were not public
Address: Vandtaarnsvej 83B
City: Copenhagen
State: other
Zip: DK-2860
Country: DK
CMC Biologics is engaged in clinical and commercial manufacturing of monoclonal antibodies, coagulation factors and therapeutic proteins.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2005 | Venture Round | 1 | $19M |
Innoven Partners Innoven Partners |
12/2004 | Series B | 1 | $11.3M |
Innoven Partners Innoven Partners Innoven Partners Innoven Partners |
1/2002 | Venture Round | 1 | - |
European Equity Partners European Equity Partners European Equity Partners European Equity Partners |
2/2008 | Venture Round | - |
Monitor Clipper Funds Monitor Clipper Funds |
2/2008 | Venture Round | 1 | - |
Monitor Clipper Funds Monitor Clipper Funds |
1/2002 | Venture Round | 1 | - |
European Equity Partners European Equity Partners European Equity Partners European Equity Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|